SCHEMBL19797130

SCHEMBL19797130

C=CC(=O)OCCOc1cc(-c2ccc(-c3ccc(OCCO)cc3)c(C)c2)ccc1C1CCC(CCCCC)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 4/20 0.36
THRB P10828 2/20 0.36
FFAR4 Q5NUL3 1/20 0.35
HRH2 P25021 1/20 0.34
HRH1 P35367 1/20 0.34
PTGES O14684 1/20 0.33
ALOX5 P09917 1/20 0.33
ITGB3 P05106 2/20 0.33
ITGA2B P08514 2/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
PTPN11 Q06124 2/20 0.33
RARA P10276 1/20 0.33
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
MMP9 P14780 1/20 0.32
MMP14 P50281 1/20 0.32
MEN1 O00255 1/20 0.32
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19804463 0.87 THRB (0.41) RARBTHRBFFAR4HRH2HRH1
SCHEMBL19796899 0.85 THRB (0.39) RARBTHRBFFAR4PTGESALOX5
SCHEMBL19796842 0.83 RAB9A (0.38) THRBFFAR4PTGESALOX5HPGD
SCHEMBL19797102 0.83 THRB (0.38) RARBTHRBFFAR4PTGESALOX5
SCHEMBL19796920 0.83 POLB (0.37) RARBPTGESALOX5ITGB3ITGA2B
SCHEMBL19796970 0.81 THRB (0.46) RARBTHRBFFAR4HRH2HRH1
SCHEMBL19796903 0.81 HPGD (0.36) THRBPTGESALOX5HPGDTSHR
SCHEMBL19797046 0.79 FFAR4 (0.33) RARBTHRBFFAR4HPGDTSHR
SCHEMBL19796835 0.78 SPHK1 (0.36) THRBFFAR4HPGDTSHRPTPN11
SCHEMBL19797103 0.78 FFAR4 (0.41) RARBTHRBFFAR4ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 RARB 3517/4885THRB 4323/4885FFAR4 1715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.